In the U.K. for more than 50 years, phototherapy has been an established low cost outpatient treatment for psoriasis and other inflammatory skin diseases.
Predominantly a hospital based secondary care service, it is commonly used prior to considering systemic therapy in those patients for whom topical treatment has proved unsatisfactory in moderate to severe disease.
Audits of phototherapy provision have revealed great variation in the quality of service provided between centres. Moves by some commissioners to provide community based phototherapy services has escalated the need for Phototherapy Service Standards, to ensure patients are not placed at risk or harmed. This, along with the legal concerns over the mismanagement and burning/overexposure to phototherapy of patients; has resulted in the development of NICE Accredited Phototherapy Service Guidance and Standards, which provide the necessary clinical and quality governance assurance.